Literature DB >> 27656831

Induction of Multidrug Resistance of Acute Myeloid Leukemia Cells by Cocultured Stromal Cells via Upregulation of the PI3K/Akt Signaling Pathway.

Ping Chen1, Qing Jin, Qiang Fu, Peidong You, Xi Jiang, Qin Yuan, Huifang Huang.   

Abstract

This study aimed to investigate the role of the PI3K/Akt signaling pathway in multidrug resistance of acute myeloid leukemia (AML) cells induced by cocultured stromal cells. Human AML cell lines HL-60 and U937 were adhesion cocultured with human bone marrow stromal cell line HS-5 cells. Such coculturing induced HL-60 and U937 cells resistant to chemotherapeutic drugs including daunorubicin (DNR), homoharringtonine (HHT), and cytosine arabinoside (Ara-C). The coculturing-induced resistance of AML cells to DNR, HHT, and Ara-C can be partially reversed by inhibition of the PI3K/Akt signaling pathway. Clinically, AML patients with a low level of PTEN and a high level of CCND1 had high relapse rates within 1 year, and newly diagnosed AML patients with extramedullary infiltration had a low level of PTEN. This study confirms the involvement of the PI3K/Akt signaling pathway in multidrug resistance in AML cells induced by stroma and suggests that the expression of PTEN and CCND1 may be a prognostic indicator for AML.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27656831     DOI: 10.3727/096504016X14634208143021

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  9 in total

1.  A drug-biomarker interaction model to predict the key targets of Scutellaria barbata D. Don in adverse-risk acute myeloid leukaemia.

Authors:  Teng Wang; Chun-Yi Lyu; Yue-Hua Jiang; Xue-Yan Dong; Yan Wang; Zong-Hong Li; Jin-Xin Wang; Rui-Rong Xu
Journal:  Mol Divers       Date:  2020-07-16       Impact factor: 2.943

2.  Identification of A-kinase interacting protein 1 as a potential biomarker for risk and prognosis of acute myeloid leukemia.

Authors:  Yan Yan; Xiaoyan Li; Jie Gao
Journal:  J Clin Lab Anal       Date:  2020-05-01       Impact factor: 2.352

3.  The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma.

Authors:  Jin Liu; Mingyi Zhu; Yun Feng; Qianli Tang; Meng Xu
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

4.  Stromal cells promote chemoresistance of acute myeloid leukemia cells via activation of the IL-6/STAT3/OXPHOS axis.

Authors:  Diyu Hou; Bin Wang; Ruolan You; Xiaoting Wang; Jingru Liu; Weiwu Zhan; Ping Chen; Tiandi Qin; Xuehao Zhang; Huifang Huang
Journal:  Ann Transl Med       Date:  2020-11

5.  TCP1 increases drug resistance in acute myeloid leukemia by suppressing autophagy via activating AKT/mTOR signaling.

Authors:  Xiaofang Chen; Xianling Chen; Yiping Huang; Jia Lin; Yong Wu; Yuanzhong Chen
Journal:  Cell Death Dis       Date:  2021-11-08       Impact factor: 8.469

6.  Decreased expression of autophagy-related genes in the complete remission phase of acute myeloid leukemia.

Authors:  Parisa Tandel; Reza Ranjbaran; Eqbal Ebrahimi; Alireza Rezvani; Mani Ramzi; Gholamhossein Tamaddon
Journal:  Mol Genet Genomic Med       Date:  2022-02-06       Impact factor: 2.183

Review 7.  Targeting of PI3K/AKT signaling and DNA damage response in acute myeloid leukemia: a novel therapeutic strategy to boost chemotherapy response and overcome resistance.

Authors:  Montserrat Estruch; Camilla Vittori; Teresa Muñoz Montesinos; Kristian Reckzeh; Kim Theilgaard-Mönch
Journal:  Cancer Drug Resist       Date:  2021-11-10

Review 8.  Targeting the Tumor Microenvironment in Acute Myeloid Leukemia: The Future of Immunotherapy and Natural Products.

Authors:  Christopher Hino; Bryan Pham; Daniel Park; Chieh Yang; Michael H K Nguyen; Simmer Kaur; Mark E Reeves; Yi Xu; Kevin Nishino; Lu Pu; Sue Min Kwon; Jiang F Zhong; Ke K Zhang; Linglin Xie; Esther G Chong; Chien-Shing Chen; Vinh Nguyen; Dan Ran Castillo; Huynh Cao
Journal:  Biomedicines       Date:  2022-06-14

9.  Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression.

Authors:  Linda S Steelman; Steve L Abrams; Peter Ruvolo; Vivian Ruvolo; Lucio Cocco; Stefano Ratti; Alberto M Martelli; Luca M Neri; Saverio Candido; Massimo Libra; James A McCubrey
Journal:  Oncotarget       Date:  2017-12-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.